MENU
RNLXY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Renalytix (RNLXY) Ownership - Who owns Renalytix?
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally... Show more
Details
Group
Domestic Stock Funds
Category
Health Services
Capitalization
33.4M
P/E Ratio
N/A
Total Cash
9.63M
Projected Growth
N/A
Total Debt
8.21M
Revenue
2.37M
Risk (Beta)
2.53
Dividend Yield
N/A
Total Cash/Share
0.06
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
RNLXY
Capitalization
33.4M
P/E Ratio
N/A
Risk (Beta)
2.53
Dividend Yield
N/A
Total Cash
9.63M
Total Cash/Share
0.06
Total Debt
8.21M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
2.37M
ROE
N/A
Book Value
-1.37M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.06M
Current Ratio
2.43
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-18.11M
Float
N/A
Float - Current
N/A
Gross Income Margin
54.60
Revenue To Assets
-136.76
Shares Held By Institutions
1.08M
Shares Outstanding - Current
166M
Total Liabilities
12.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-18.591
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RNLXY showed earnings on March 18, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information